Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) EPS (Weighted Average and Diluted) (2023 - 2025)

Fractyl Health's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.07 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 86.79% year-over-year to -$0.07, compared with a TTM value of -$1.84 through Dec 2025, down 19.48%, and an annual FY2025 reading of -$1.86, down 14.81% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.07 at Fractyl Health, up from -$0.71 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.07 in Q4 2025, with the low at -$16.62 in Q2 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$4.06, with a median of -$0.55 recorded in 2025.
  • Year-over-year, EPS (Weighted Average and Diluted) soared 97.84% in 2024 and then crashed 188.24% in 2025.
  • Tracing GUTS's EPS (Weighted Average and Diluted) over 3 years: stood at -$11.18 in 2023, then skyrocketed by 95.26% to -$0.53 in 2024, then surged by 86.79% to -$0.07 in 2025.
  • Per Business Quant, the three most recent readings for GUTS's EPS (Weighted Average and Diluted) are -$0.07 (Q4 2025), -$0.71 (Q3 2025), and -$0.57 (Q2 2025).